Liquid Dosage
Blood Plasma Fractionation
The processing of blood into its various components must meet the very highest requirements to ensure clinical excellence. Because of the inherent variability of the source material and the absolute need for product purity, the demands placed on systems used to manufacture blood- and plasma-derived products are huge. Gentle process conditions and high quality equipment are essential.
The GEA Advantage
A specialist in this field, GEA uses its experience and expertise to unite a range of technologies to create complete processing plants for blood plasma processing, including controlled precipitation, centrifugation and filtration for solid/liquid separation, thermal and chemical inactivation, ultrafiltration/diafiltration, nanofiltration and chromatography. The company has successfully planned and built plants for blood plasma fractionation all over the world.
GEA supplies plant and components for fractionation, concentration, pre- and post-virus inactivation, purification and buffer production, storage and distribution. As well as being an aseptic process, blood plasma fractionation involves precise cooling of the separation vessel at various stages, requiring highly accurate control systems. Depending on the application, plasma may need to be frozen to –30 °C within 60 minutes. GEA can supply equipment to accurately maintain such extremely low temperatures.
An essential part of high-quality blood plasma production is an integrated CIP/SIP system. GEA provides efficient cleaning and sterilization processes to meet your individual demands and to ensure that sterile media is delivered to the right place at the right time. We offer a wide range of cleaning options, from mobile, independent cleaning systems up to diverse CIP satellites fed with conditioned cleaning solutions.
High Standards, High Quality
In addition, the process must comply with a large number of national and international standards and statutory provisions. Manufacturers expect great precision in the manufacture and assembly of their process plant; every detail of the design must comply with the highest standards to avoid production errors. Using high-performance processing equipment from GEA helps to guarantee reliable production.
Whatever you need your process plant for — from the fractionation and manufacture of products such as immunoglobulins or human albumins to Factor VIII/Factor IX — our wide range of plant concepts will provide for any task to be performed in a safe and cost-effective way and take account of any specific requirements or conditions.
製品および技術
8 の 4 を表示する
CIP/SIP ソリューション
GEA の革新的な CIP コンセプトは、包括的な最高規格を満たしています。当社のエキスパートは、プロセスのあらゆる時点で、製品の安全性を保証しています。どのアップグレードも、現場の個々の条件および顧客の要件に適合し、顕著な節約を実現します。
Hygienic pumps
GEA Hilgeでは、飲料、食品、製薬産業における多岐にわたる感度の高い用途に汎用性の高い遠心ポンプおよび容積型ポンプをご用意しております。
Lyophilizers (Pharma Freeze Dryers)
GEA's thorough understanding of the lyophilization process enables them to supply a comprehensive range of products and services, comprising laboratory equipment, pilot plants for research and small-scale production batches, industrial size pharmaceutical production freeze dryers.
サニタリ仕様バルブ & コンポーネント
GEA のサニタリ仕様バルブは、マトリックスパイププロセスプラントの中核コンポーネントを構成します。柔軟性の基準を設定する先駆的なバルブの概念と、最新の制御および自動化機能により、当社のバルブでは製造業者の最大限の製品の安全性とプロセスの信頼性が得られます。全ての GEA サニタリ仕様バルブは、その用途に対して効率的で費用対効果が高くなるよう設計されており、持続可能な操業と大幅な節約につながります。
Downloads
GEAインサイト
All pharmaceutical freeze-drying vials are the same! Aren't they?
Whether it’s a fad or the future, 100% vial traceability is becoming an increasingly important consideration in the pharmaceutical freeze drying industry. Keeping a close eye on developments is GEA. We’re investigating possible solutions and, what’s more, we have the experience, expertise and know-how to implement them.
Innovating patient care with aseptic spray drying
At GEA, our commitment to engineering for a better world fuels our pursuit of innovative solutions that enhance patient care and safety. One of our most promising ventures in recent years is aseptic spray drying – a technology that promises to revolutionize pharmaceutical manufacturing.
